Innospec Inc. Liquidation Value

IOSP Chemicals

Cash & Equivalents

$289.10M
As of 2026-03-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $289.10M
Total Obligations: -$420.90M
$-131.80M
Per share: $-5.32
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $289.10M
AR: $354.20M
Total Obligations: -$420.90M
$222.40M
Per share: $8.98
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $289.10M
AR: $354.20M
Inventory: $321.50M
Total Obligations: -$420.90M
$543.90M
Per share: $21.95
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-131.80M$-5.32
Liquid Liquidation Value$222.40M$8.98
Operating Liquidation Value$543.90M$21.95

Key Components (as of 2026-03-31)

Data as of 2026-03-31 from 10-Q filed 2026-05-08. View on SEC EDGAR →

Cash & Equivalents$289.10M
Accounts Receivable$354.20M
Inventory$321.50M
Current Liabilities$334.80M
Long-term Debt (?)N/A
Op. Lease Liability (?)$35.50M
Finance Lease (?)N/A
Shares Outstanding24.8M

Explore all 121 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$289.10M$354.20M$321.50M$138.50M$334.80MN/A$35.50MN/A
2025-12-31$292.50M$342.30M$329.30M$174.70M$360.10MN/A$36.80MN/A
2025-09-30$270.80M$349.50M$345.20M$162.20M$356.10MN/A$33.00MN/A
2025-06-30$266.60M$336.10M$336.80M$149.40M$337.40MN/A$33.70MN/A
2025-03-31$299.80M$343.50M$315.40M$169.50M$357.60MN/A$30.40MN/A
2024-12-31$289.20M$341.70M$301.00M$163.80M$371.40MN/A$31.00MN/A
2024-09-30$303.80M$327.60M$319.30M$169.00M$373.10MN/A$31.70MN/A
2024-06-30$240.20M$300.30M$313.50M$147.70M$332.80MN/A$33.20MN/A

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-05-08 View
2025-12-31 10-K 2026-02-18 View
2025-09-30 10-Q 2025-11-05 View
2025-06-30 10-Q 2025-08-06 View
2025-03-31 10-Q 2025-05-09 View
2024-12-31 10-K 2025-02-19 View
2024-09-30 10-Q 2024-11-06 View
2024-06-30 10-Q 2024-08-07 View

AI Insights

AI Insight·Generated 2026-05-09

INNOSPEC INC. (IOSP) 10-Q for the quarter ended March 31, 2026 presents a balance sheet that supports positive equity recovery under a liquidation scenario, though the recoverable value is substantially below book equity due to the standard haircut asymmetries. Total assets are $1,819.8M against total liabilities of $467.6M, yielding book equity of $1,352.2M (including $7.2M minority interest). Under the liquidation lens, the primary value-destroying items are goodwill ($399.1M, zero recovery), other intangibles net of amortization ($68.9M, zero recovery), and the PP&E haircut on $285.7M net book value (50-70% recovery implies $85-143M loss vs. book). Liquid assets are favorable: cash of $289.1M recovers at par; AR of $354.2M gross (less $14.2M allowance) recovers at 90-95% of net, implying minimal additional loss. Inventory of $321.5M net (after $39.4M reserve) applies a 60% recovery haircut, destroying roughly $128M vs. carrying value. Operating lease ROU asset of $50.6M is non-recoverable intangible in nature, while the corresponding lease liability of $50.6M ($15.1M current + $35.5M noncurrent) remains at full face value — net zero or slightly negative depending on termination terms. The defined benefit pension obligation ($12.8M noncurrent + $9.1M legacy) is a hard liability at face. The restructuring reserve of $65.7M ($4.9M current, $60.8M noncurrent) represents committed legacy closure obligations that do not extinguish in a wind-down and must be settled at face. The company carries zero funded debt — the $250M revolving credit facility is undrawn as of March 31, 2026 — which is the single most important structural feature for equity recovery; absence of funded debt eliminates the largest typical claim subordinating equity. MFFAIS CLV is reported at negative $81.2M, LLV at $273.0M, OLV at $594.5M, consistent with this analysis: cash + working capital positive but goodwill/intangibles and restructuring liabilities suppress CLV below zero. The prior filing was the 2025 Form 10-K (annual); the 10-Q shows modest QoQ changes: cash declined $3.4M to $289.1M, inventory declined $7.8M, AR increased $11.9M, restructuring reserve increased $2.3M net. The $4.7M contingent consideration fair value credit in Q1 2026 (vs. $0.7M expense in Q1 2025) reduced the contingent consideration liability, with the current portion dropping from $7.0M to $2.7M — a $4.3M improvement in this liability. The company notes in MD&A that it is amortizing a new ERP system (capitalized software development of $5.1M invested in the quarter), which will be tagged as intangible and recover at zero under the lens. The filing also discloses an ongoing unresolved misappropriation of inventory in Brazil with no recovery asset recorded, an unquantified tail risk. A new $75M buyback program was announced post-period (May 7, 2026), replacing the prior $50M program; this will reduce cash available in future periods.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...